ID   A549 ATGL-KO
AC   CVCL_UJ32
DR   cancercelllines; CVCL_UJ32
DR   PRIDE; PXD007223
DR   Wikidata; Q93311893
RX   PubMed=29457907;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 30802; PNPLA2.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
RX   PubMed=29457907; DOI=10.1021/acs.jproteome.7b00782;
RA   Tomin T., Fritz K., Gindlhuber J., Waldherr L., Pucher B.,
RA   Thallinger G.G., Nomura D.K., Schittmayer M., Birner-Gruenberger R.;
RT   "Deletion of adipose triglyceride lipase links triacylglycerol
RT   accumulation to a more-aggressive phenotype in A549 lung carcinoma
RT   cells.";
RL   J. Proteome Res. 17:1415-1425(2018).
//